An alternative mechanism of AR activation independent of androgen binding includes its phosphorylation via kinases [e.g., epidermal growth factor receptor (EGFR)] in, for instance, prostate cancer cells [15,16,17]. This evidence concerns the gene EGFR and prostate carcinoma.